UNSPSC 51343101: Idoxuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11IN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LGP81V5245, chemically known as uridine, 5-iodo-2-deoxy- but generally known as idoxuridine, which bears US NIH Compound Identifier 3687. European Medicines Agency schedules Idoxuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08117MIG.

UNSPSC 51343101 Idoxuridine, a Commodity code, shows little relevant recent activity aligned with its nominal scope. The two state and local contract opportunities tagged to this code are unrelated to idoxuridine — one is a completed pharmaceutical warehouse piggyback award by the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and the other is an open procurement by Seminole County, Florida for Naloxone and Safe Drug Deactivation Systems. Neither represents sourcing of idoxuridine specifically. The code's nominal target — a specific antiviral pharmaceutical — does not align with the actual purchasing signals present in the available recent opportunities.

The tagging mismatch suggests the code may not reflect active state and local procurement demand for idoxuridine at this time, or that sourcing under this code is being misclassified in available records. Business development professionals evaluating this code should verify directly with issuing agencies whether idoxuridine procurement is occurring under related pharmaceutical codes or through cooperative purchasing arrangements such as MMCAP or state-level group purchasing organizations, which appear to be active channels for pharmaceutical supply in this region.